Bambusa Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- May 15, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $90,000,000
Company Info
- Company Description
- Bambusa Therapeutics is a biotechnology company developing bispecific antibodies for immunological and inflammatory disorders.
- Market
- Immunological and inflammatory disorders
- Location
- Boston, MA, USA
- Coinvestors
- RA Capital Management, Janus Henderson Investors, Redmile Group, Invus, ADAR1 Capital Management